AU3240900A - Solid oral dosage form containing heparin or a heparinoid in combination with a carrier - Google Patents

Solid oral dosage form containing heparin or a heparinoid in combination with a carrier

Info

Publication number
AU3240900A
AU3240900A AU32409/00A AU3240900A AU3240900A AU 3240900 A AU3240900 A AU 3240900A AU 32409/00 A AU32409/00 A AU 32409/00A AU 3240900 A AU3240900 A AU 3240900A AU 3240900 A AU3240900 A AU 3240900A
Authority
AU
Australia
Prior art keywords
heparinoid
carrier
combination
dosage form
oral dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU32409/00A
Inventor
Kenneth Iain Cumming
Mary L. Martin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Emisphere Holdings Inc
Original Assignee
Emisphere Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emisphere Technologies Inc filed Critical Emisphere Technologies Inc
Publication of AU3240900A publication Critical patent/AU3240900A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
AU32409/00A 1999-02-22 2000-02-22 Solid oral dosage form containing heparin or a heparinoid in combination with a carrier Abandoned AU3240900A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12106599P 1999-02-22 1999-02-22
US60121065 1999-02-22
PCT/US2000/004559 WO2000048589A1 (en) 1999-02-22 2000-02-22 Solid oral dosage form containing heparin or a heparinoid in combination with a carrier

Publications (1)

Publication Number Publication Date
AU3240900A true AU3240900A (en) 2000-09-04

Family

ID=22394277

Family Applications (1)

Application Number Title Priority Date Filing Date
AU32409/00A Abandoned AU3240900A (en) 1999-02-22 2000-02-22 Solid oral dosage form containing heparin or a heparinoid in combination with a carrier

Country Status (2)

Country Link
AU (1) AU3240900A (en)
WO (1) WO2000048589A1 (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6461643B2 (en) 1993-04-22 2002-10-08 Emisphere Technologies, Inc. Oral drug delivery compositions and methods
US6001347A (en) 1995-03-31 1999-12-14 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
SI9720025A (en) 1996-03-29 1999-08-31 Emishphere Technologies, Inc. Compounds and compositions for delivering active agents
US6358504B1 (en) 1997-02-07 2002-03-19 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6440929B1 (en) 1998-07-27 2002-08-27 Emisphere Technologies, Inc. Pulmonary delivery of active agents
WO2000006184A1 (en) 1998-07-27 2000-02-10 Emisphere Technologies, Inc. Pulmonary delivery of active agents
CA2369591C (en) 1999-04-05 2011-06-14 Emisphere Technologies, Inc. Disodium salts, monohydrate, and ethanol solvates
ITMI20012599A1 (en) 2001-12-11 2003-06-11 Cosmo Spa PHARMACEUTICAL COMPOSITIONS FOR THE ORAL ADMINISTRATION OF HEPARINE OR DERIVATIVES, USEFUL FOR THERAPY OF INFLAMMATORY DISEASES OF THE INT
US9308220B2 (en) 2001-12-11 2016-04-12 Cosmo Technologies Limited Pharmaceutical compositions for the oral administration of heparin or derivatives thereof
US20080132527A1 (en) 2004-05-19 2008-06-05 Emisphere Technologies, Inc. Compositions For Delivering Acyclovir
CN1968704B (en) 2004-05-19 2010-12-08 爱密斯菲尔科技公司 Topical cromolyn formulations
US9399054B2 (en) * 2004-07-12 2016-07-26 Emisphere Technologies, Inc. Compositions for delivering peptide YY and PYY agonists
WO2006072070A2 (en) 2004-12-29 2006-07-06 Emisphere Technologies, Inc. Pharmaceutical formulations of gallium salts
US8110547B2 (en) 2005-01-12 2012-02-07 Emisphere Technologies, Inc. Compositions for buccal delivery of parathyroid hormone
ES2540929T3 (en) * 2005-02-01 2015-07-14 Emisphere Technologies, Inc. Gastric retention and controlled release administration system
WO2007011958A2 (en) 2005-07-15 2007-01-25 Emisphere Technologies, Inc. Intraoral dosage forms of glucagon
EP1792621B1 (en) 2005-11-30 2012-04-04 Istituto di Ricerche Chimiche e Biochimiche "G. Ronzoni" Orally administrable heparin derivatives
WO2007121318A2 (en) 2006-04-12 2007-10-25 Emisphere Technologies, Inc. Formulations for delivering insulin
WO2008003050A2 (en) 2006-06-28 2008-01-03 Emisphere Technologies, Inc. Gallium nitrate formulations
CL2007002618A1 (en) * 2006-09-12 2008-03-14 Glaxo Group Ltd PHARMACEUTICAL COMPOSITION OF ORAL MODIFIED RELEASE UNDERSTANDING A MINI-COMPRESSED PLURALITY WITH A DIAMETER LESS THAN 5 MM AND UNDERSTANDING AN XA FACTOR INHIBITOR WITHIN A MATRIX OF ONE OR MORE POLYMERS; PREPARATION PROCEDURE
EP2461803B1 (en) 2009-08-03 2018-10-17 Emisphere Technologies, Inc. Fast-acting naproxen composition with reduced gastrointestinal effects
DK3326620T3 (en) 2010-12-16 2020-05-25 Novo Nordisk As SOLID COMPOSITIONS CONTAINING A GLP-1 AGONIST AND SALT OF N- (8- (2- HYDROXYBENZOYL) AMINO) CAPRYLIC ACID
MX355361B (en) 2011-04-12 2018-04-17 Novo Nordisk As Double-acylated glp-1 derivatives.
AU2013234496B2 (en) 2012-03-22 2017-07-27 Novo Nordisk A/S Compositions of GLP-1 peptides and preparation thereof
HUE042757T2 (en) 2012-03-22 2019-07-29 Novo Nordisk As Compositions comprising a delivery agent and preparation thereof
EP4331667A2 (en) 2012-03-22 2024-03-06 Novo Nordisk A/S Compositions comprising a delivery agent and preparation thereof
ES2871328T3 (en) 2012-06-20 2021-10-28 Novo Nordisk As Tablet formulation comprising a peptide and a delivery agent
CA2975710C (en) 2015-02-09 2023-08-08 Entera Bio Ltd. Treatment of osteoporosis
IL275778B2 (en) 2018-02-02 2023-12-01 Novo Nordisk As Solid compositions comprising a glp-1 agonist, a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid and a lubricant

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650386A (en) * 1995-03-31 1997-07-22 Emisphere Technologies, Inc. Compositions for oral delivery of active agents
US6001347A (en) * 1995-03-31 1999-12-14 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents

Also Published As

Publication number Publication date
WO2000048589A1 (en) 2000-08-24

Similar Documents

Publication Publication Date Title
AU3240900A (en) Solid oral dosage form containing heparin or a heparinoid in combination with a carrier
AU5259100A (en) Medicament
GB9912130D0 (en) High speed parallel
AU4939400A (en) Meter
AU3923700A (en) Dental materials
GB9930079D0 (en) Medicaments
GB9930071D0 (en) Medicaments
AU2692200A (en) Enteral sorbefacients
SI1176982T1 (en) Prucalopride oral solution
GB9906149D0 (en) Polymer composition
HUP0202652A3 (en) Pharmaceutical carrier composition
GB9930083D0 (en) Medicaments
GB9924990D0 (en) Medicaments
GB2349803B (en) Improvements in shelving
AU141528S (en) Counter
GB9929040D0 (en) Medicaments
GB9908613D0 (en) Mailing pack
AU7655700A (en) Medicament combinations
AU7591900A (en) Forward-error-correction interleaving
GB9912631D0 (en) Cell counter
HK1044801A1 (en) A blood detection composition
AU2077901A (en) Craze-resistant polymeric article
GB9904935D0 (en) Medicaments
GB9929039D0 (en) Medicaments
AUPP458398A0 (en) Parcel delivery safe

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase